Hábitos de sueño saludable, melatonina y cáncer de mama

Autores/as

  • M. Santisteban Oncología Médica Clínica Universidad de Navarra Pamplona

DOI:

https://doi.org/10.23938/ASSN.0714

Descargas

Los datos de descargas todavía no están disponibles.

Citas

HE C, ANAND ST, EBELL MH, VENA JE, ROBB SW. Circadian disrupting exposures and breast cancer risk: a meta-analysis. Int Arch Occup Environ Health 2015; 88: 533-547. https://doi.org/10.1007/s00420-014-0986-x

BRAINARD GC, HANIFIN JP, GREESON JM, BYRNE B, GLICKMAN G, GERNER E et al. Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci 2001; 21: 6405-6412. https://doi.org/10.1523/jneurosci.21-16-06405.2001

ACUÑA-CASTROVIEJO D, ESCAMES G, VENEGAS C, DÍAZ-CASADO ME, LIMA-CABELLO E, LÓPEZ LC et al. Extrapineal melatonin: sources, regulation and potential functions. Cell Mol Life Sci 2014; 71: 2997-3025. https://doi.org/10.1007/s00018-014-1579-2

MENÉNDEZ-MENÉNDEZ J, MARTÍNEZ-CAMPA C. Melatonin: an anti-tumor agent in hormone-dependent cancers. Int J Endocrinol 2018. tps://doi.org/10.1155/2018/3271948

SALAMANCA-FERNÁNDEZ E, RODRÍGUEZ-BARRANCO M, GUEVARA M, ARDANAZ E, OLRY DE LABRY LIMA A, SÁNCHEZ MJ. Night-shift work and breast and prostate cancer risk: updating the evidence from epidemiological studies.. An Sist Sanit Navar 2018; 41: 211-226. https://doi.org/10.23938/ASSN.0307

STRAIF K, BAAN R, GROSSE Y, SECRETAN B, EL GHISSASSI F, BOUVARD V, et al; WHO International Agency For Research on Cancer Monograph Working Group. Lancet Oncol 2007; 8: 1065-1066.

TRUONG T, LIQUET B, MENEGAUX F, PLANCOULAINE S, LAURENT-PUIG P, MULOT C et al. Breast cancer risk, nightwork, and circadian clock gene polymorphisms. Endocr Relat Cancer 2014; 21: 629-638. https://doi.org/10.1016/s1470-2045(07)70099-2

HILL SM, BELANCIO VP, DAUCHY RT, XIANG S, BRIMER S, MAO L et al. Melatonin: an inhibitor of breast cancer. Endocr Relat Cancer 2015; 22: 183-204. https://doi.org/10.1530/ERC-15-0030

JABLONSKA K, PULA B, ZEMLA A, OWCZAREK T, WOJNAR A, RYS J et al. Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma. J Pineal Res 2013; 54: 334-345. https://doi.org/10.1111/jpi.12032

LAPIN V, EBELS I. Effects of some low molecular weight sheep pineal fractions and melatonin on different tumors in rats and mice. Oncology. 1976; 33:110-113. https://doi.org/10.1159/000225117

DENT R, TRUDEAU M, PRITCHARD KI, HANNA WM, KAHN HK, SAWKA CA et al. Triple negative breast cancer: clinical features and pattern of recurrences. Clin Cancer Res 2007; 13: 4429-4434. https://doi.org/10.1158/1078-0432.ccr-06-3045

U.S. NATIONAL LIBRARY OF MEDICINE. Database of privately and publicly funded clinical studies conducted around the world. Breast cancer and melatonin. www.clinicaltrials.gov

Descargas

Publicado

2019-08-23

Cómo citar

Santisteban, M. (2019). Hábitos de sueño saludable, melatonina y cáncer de mama. Anales Del Sistema Sanitario De Navarra, 42(2), 245–248. https://doi.org/10.23938/ASSN.0714

Número

Sección

Cartas al editor

Artículos similares

También puede {advancedSearchLink} para este artículo.